Freenome, Inc. (FRNM) stock
Close on Nov 13, 2026Market cap $1.15BP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026
Valuation
- Market cap
- $1.15B
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 2.40
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- $109.43M
- Book value per share
- $4.66
- Diluted shares
- 103M
Trading
- Previous close
- $10.61
- Open
- $10.50
- Day's range
- $9.95 – $10.70
- Volume
- 615,408
- Average volume (20 days)
- 780,512
- Beta (5 years)
- 0.23
- 52-week range
- $9.71 – $17.50
- RSI (14 days)
- 35.7
- Volatility (1 year)
- 51.1%
- Relative volume
- 0.77×
- WACC
- 7.6%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | FRNM | S&P 500 | Difference | FRNM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -17.6% | -3.0% | −14.6 pts | ||
| 3 months | -10.3% | -2.8% | −7.6 pts | ||
| Year to date | -20.1% | +11.5% | −31.6 pts | ||
| 1 year | -3.5% | +13.5% | −17.0 pts |
Two years at a glance
Fiscal years 2024 to 2025 and trailing twelve months, USD
Operating income
Net income
Press releases
Releases Freenome filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Update
- Update
- Update
About Freenome
Services-Medical Laboratories
Perceptive Capital Solutions Corp operates as a blank check company established to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The entity does not manufacture commercial products, offer services, or maintain distinct operating business segments. Because it functions as an acquisition vehicle rather than an operating commercial enterprise, the company does not serve commercial clients or retail consumers. Instead, its core business activity centers on identifying, evaluating, and negotiating a potential initial transaction with private or public operating enterprises, concentrating primarily on companies within the healthcare sector, specifically life sciences and medical technology.
Company profile, executives and historyFreenome stock: common questions
What is Freenome's stock price?
FRNM closed at $10.41 on Nov 13, 2026, down 1.89% on the day. Over the past 52 weeks it traded between $9.71 and $17.50.
What is Freenome's market cap?
Freenome was worth $1.15B at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
Does Freenome pay a dividend?
No. Freenome has not paid a cash dividend over the last twelve months.
How has FRNM stock performed over the past year?
Including dividends, FRNM returned -3.5% over the past year, against +13.5% for the S&P 500.
How many FRNM shares are sold short?
5M shares were sold short at the latest FINRA report, 6.46% of the float, or 8.1 days of average trading volume.
Who are Freenome's competitors?
Companies most similar to Freenome by business, industry and size include YDES, PSNL, RNLXY, ADVB, FLGT.
See a number that looks wrong?